Your browser doesn't support javascript.
loading
Population Pharmacokinetic Modeling and Exposure-Response Analysis for Aripiprazole Once Monthly in Subjects With Schizophrenia.
Wang, Xiaofeng; Raoufinia, Arash; Bihorel, Sébastien; Passarell, Julie; Mallikaarjun, Suresh; Phillips, Luann.
Affiliation
  • Wang X; Otsuka Pharmaceutical Development & Commercialization, Inc., Rockville, Maryland, USA.
  • Raoufinia A; Otsuka Pharmaceutical Development & Commercialization, Inc., Rockville, Maryland, USA.
  • Bihorel S; Cognigen Corporation, a SimulationsPlus Company, Buffalo, New York, USA.
  • Passarell J; Cognigen Corporation, a SimulationsPlus Company, Buffalo, New York, USA.
  • Mallikaarjun S; Otsuka Pharmaceutical Development & Commercialization, Inc., Rockville, Maryland, USA.
  • Phillips L; Fellow of the American College of Clinical Pharmacology (FCP).
Clin Pharmacol Drug Dev ; 11(2): 150-164, 2022 02.
Article in En | MEDLINE | ID: mdl-34979059
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Schizophrenia / Antipsychotic Agents / Quinolones Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: Clin Pharmacol Drug Dev Year: 2022 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Schizophrenia / Antipsychotic Agents / Quinolones Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: Clin Pharmacol Drug Dev Year: 2022 Document type: Article Affiliation country: Country of publication: